Guilin Sanleng Biotech Co. Ltd. is specified in production and supply of medicinal APIs, purified single molecules, intermediates, crude extracts, and polysaccharides from plants or TCM herbs. Currently we have two facilities in Guilin, with an annual manufacturing capacity of more than 3,000 metric tons of medicinal plants. Our facilities are well equipped for extraction, concentration, partition, low temperature storage, column chromatography purification, spray and vacuum drying, and QC laboratories, and were GMP audited and certified in the end of 2003 by China authorities and also by an European pharmaceutical company in the Spring of 2004.
Our R&D Center (Medicass Biotechnologies, Co.) is established in Beijing, aiming at process development, pilot scale-up, process finalization, analytical and QC method development and establishment, and new pharmaceutical research and development. The pilot facilities in Beijing, which were GMP audited and verified by an European pharmaceutical company in both 2004 and 2005, are also used in small scale production of highly potent APIs, small molecules, and polysaccharides. Equipment such as HPLC, GC, GC-MS, LC-MS, IR, NMR are routinely used in our laboratories for analysis and quality controls of our products.
Taking advantage of the abundant plants or TCM herbs in southwest of China, we are fully exploring and developing pharmaceutical APIs, crude extracts, intermediates and starting materials derived from locally collected plants and TCM herbs. Now we have more than 30 products to offer, including Andrographis paniculata product series, Tripterygium wilfordii product series, plant polysaccharide series, Diospyros kaki P.E, Arteminine, Momordica P.E, Ginkgo P.E, Passiflora incarnata P.E, and Psidium guajava L.P.E, etc.
Our mission is to take honesty and integrity as basis for a win-win objective.